Enorama Pharma AB (publ) (STO: ERMA)

Enorama Pharma AB Revenue

Enorama Pharma AB had revenue of 7.49M SEK in the quarter ending September 30, 2024, with 14,586.27% growth. This brings the company's revenue in the last twelve months to 13.26M, up 751.09% year-over-year. In the year 2023, Enorama Pharma AB had annual revenue of 1.36M, down -80.17%.

• Revenue (ttm): 13.26M
• Revenue Growth: +751.09%
• P/S Ratio: n/a
• Revenue / Employee: 2.65M
• Employees: 5
• Market Cap: 247.34M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.36M	-5.49M	-80.17%
Dec 31, 2022	6.85M	-5.95M	-46.50%
Dec 31, 2021	12.80M	8.33M	186.40%
Dec 31, 2020	4.47M	-5.97M	-57.17%
Dec 31, 2019	10.44M	-1.54M	-12.89%